Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-21-000007

Options or other derivatives

  • Chief Executive Officer acquired 163,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

FOUSE JACQUALYN A · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-10 Grant or award : show line 1 in the form Stock option (right to buy) +163,000 163,000 D
Loading xslF345X03/wf-form4_161316500956020.xml…